Results
20,929 records
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 18 | Peetz ChristopherDirector, CHIEF EXECUTIVE OFFICER |  MIRMMirum Pharmaceuticals, Inc.Open-market sale · 10b5-1 plan | SELL | $1.80M 20.0K sh | Nov 4, 2026 |
Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 18 | Peetz ChristopherDirector, CHIEF EXECUTIVE OFFICER | MIRMMirum Pharmaceuticals, Inc. Open-market sale · 10b5-1 plan | SELL | $1.80M 20.0K sh | Nov 4, 2026 |
| 18 | Tsao DavidDirector, Chief Technology Officer |  BLLNBillionToOne, Inc.Open-market sale · 10b5-1 plan | SELL | $353K 3,241 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 18 | Tsuchimoto Kim RDirector |  MNPRMonopar TherapeuticsOpen-market sale · 10b5-1 plan | SELL | $43K 600 sh | Nov 4, 2026 traded Nov 4, 2026 |
| 17 | Kleinerman ChristianEVP, Product Management |  SNOWSnowflake Inc.Open-market sale · 10b5-1 plan | SELL | $3.06M 10.0K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 17 | Murray Jason HulseDirector, Co-Founder, CEO & Chairman, 10% Owner |  PACSPACS Group, Inc.Open-market sale · 10b5-1 plan | SELL | $1.34M 29.1K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 17 | Murray Jason HulseDirector, Co-Founder, CEO & Chairman, 10% Owner | PACSPACS Group, Inc. Open-market sale · 10b5-1 plan | SELL | $6.71M 133.3K sh | Nov 4, 2026 traded Nov 4, 2026 |
| 17 | Stat Lauren Elaina FriedmanDirector |  PLTRPalantir Technologies Inc.Open-market sale · 10b5-1 plan | SELL | $253K 1,358 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 17 | Hendry Gregory LChief Accounting Officer |  PMTPennyMac Mortgage Investment TrustOpen-market sale · 10b5-1 plan | SELL | $19K 2,443 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 17 | Wassenaar YvonneDirector |  RBRKRubrik, Inc.Open-market sale · 10b5-1 plan | SELL | $84K 721 sh | Nov 4, 2026 traded Nov 4, 2026 |
| 17 | Puri Michal NathChief Human Resources Officer |  NVCRNovoCure LtdOpen-market sale | SELL | $8,738 660 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 17 | Hancock MarkDirector, 10% Owner | PACSPACS Group, Inc. Open-market sale · 10b5-1 plan | SELL | $8.81M 174.9K sh | Nov 4, 2026 traded Nov 4, 2026 |
| 17 | Palmer Benjamin EdwardSVP, Pres Commercial |  VSATVIASAT INCOpen-market sale · 10b5-1 plan | SELL | $154K 2,000 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 17 | Anderson RaymondDirector | MNPRMonopar Therapeutics Open-market sale · 10b5-1 plan | SELL | $56K 840 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 17 | Tsuchimoto Kim RDirector | MNPRMonopar Therapeutics Open-market sale · 10b5-1 plan | SELL | $92K 1,295 sh | Nov 4, 2026 traded Nov 4, 2026 |
| 16 | Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS |  NTRANatera, Inc.Open-market sale · 10b5-1 plan | SELL | $176K 432 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 16 | Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS | NTRANatera, Inc. Open-market sale · 10b5-1 plan | SELL | $164K 410 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 16 | Swanson Luke RoyCHIEF TECHNOLOGY OFFICER |  IBTAIbotta, Inc.Open-market sale · 10b5-1 plan | SELL | $145K 2,363 sh | Nov 4, 2026 traded Nov 3, 2026 |
| 16 | Brophy Michael BurkesCHIEF FINANCIAL OFFICER | NTRANatera, Inc. Open-market sale · 10b5-1 plan | SELL | $184K 470 sh | Nov 4, 2026 traded Nov 3, 2026 |
| 16 | Coloma Jason VDirector, Chief Executive Officer |  MAZEMaze Therapeutics, Inc.Open-market sale · 10b5-1 plan | SELL | $799K 26.6K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 16 | Bhutani Amanpal SinghDirector, Chief Executive Officer |  GDDYGoDaddy Inc.Open-market sale · 10b5-1 plan | SELL | $530K 4,500 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 16 | Kasbar Michael JDirector, Executive Chairman |  WKCWORLD KINECT CORPOpen-market sale · 10b5-1 plan | SELL | $292K 8,062 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 16 | Cochran CarolineDirector, Co-Founder, COO, 10% Owner |  OKLOOklo Inc.Open-market sale · 10b5-1 plan | SELL | $172K 6,700 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 16 | Vassil JonathanChief Revenue Officer |  TOSTToast, Inc.Open-market sale · 10b5-1 plan | SELL | $373K 11.1K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 16 | Leach BryanDirector, CEO AND PRESIDENT, 10% Owner | IBTAIbotta, Inc. Open-market sale · 10b5-1 plan | SELL | $63K 1,129 sh | Nov 4, 2026 traded Nov 3, 2026 |
| 16 | Leach BryanDirector, CEO AND PRESIDENT, 10% Owner | IBTAIbotta, Inc. Open-market sale · 10b5-1 plan | SELL | $150K 2,738 sh | Nov 4, 2026 traded Nov 3, 2026 |
| 16 | Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS | NTRANatera, Inc. Open-market sale · 10b5-1 plan | SELL | $166K 408 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 16 | Nonko EugeneDirector |  MAXMediaAlpha, Inc.Open-market sale · 10b5-1 plan | SELL | $1.43M 93.3K sh | Nov 4, 2026 traded Nov 4, 2026 |
| 16 | Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS | NTRANatera, Inc. Open-market sale · 10b5-1 plan | SELL | $100K 240 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 16 | Yi StevenDirector, See Remarks | MAXMediaAlpha, Inc. Open-market sale · 10b5-1 plan | SELL | $1.96M 130.1K sh | Nov 4, 2026 traded Nov 3, 2026 |
| 16 | DeWitte JacobDirector, Co-Founder, CEO, 10% Owner | OKLOOklo Inc. Open-market sale · 10b5-1 plan | SELL | $172K 6,700 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 16 | DeWitte JacobDirector, Co-Founder, CEO, 10% Owner | OKLOOklo Inc. Open-market sale · 10b5-1 plan | SELL | $172K 6,700 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 16 | Cochran CarolineDirector, Co-Founder, COO, 10% Owner | OKLOOklo Inc. Open-market sale · 10b5-1 plan | SELL | $172K 6,700 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 16 | Fesko JohnPRESIDENT, CHIEF BUS. OFFICER | NTRANatera, Inc. Open-market sale · 10b5-1 plan | SELL | $118K 295 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 16 | Yi StevenDirector, See Remarks | MAXMediaAlpha, Inc. Open-market sale · 10b5-1 plan | SELL | $2.34M 151.1K sh | Nov 4, 2026 traded Nov 4, 2026 |
| 16 | Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS | NTRANatera, Inc. Open-market sale · 10b5-1 plan | SELL | $213K 520 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 16 | Rabinowitz DanielSEC. AND CHIEF LEGAL OFFICER | NTRANatera, Inc. Open-market sale · 10b5-1 plan | SELL | $134K 334 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 16 | Brophy Michael BurkesCHIEF FINANCIAL OFFICER | NTRANatera, Inc. Open-market sale · 10b5-1 plan | SELL | $127K 317 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 16 | Swanson Luke RoyCHIEF TECHNOLOGY OFFICER | IBTAIbotta, Inc. Open-market sale · 10b5-1 plan | SELL | $185K 3,094 sh | Nov 4, 2026 traded Nov 3, 2026 |
| 16 | Swanson Luke RoyCHIEF TECHNOLOGY OFFICER | IBTAIbotta, Inc. Open-market sale · 10b5-1 plan | SELL | $212K 3,283 sh | Nov 4, 2026 traded Nov 3, 2026 |
| 16 | Bidzos D JamesDirector, Exec. Chairman, Pres, & CEO |  VRSNVERISIGN INC/CAOpen-market sale · 10b5-1 plan | SELL | $357K 1,160 sh | Nov 4, 2026 traded Nov 3, 2026 |